News › Clinical Practice, Industry News, Patient Care, Spotlights

Biospecimen Study Provides Data for Systemic Symptoms of Breast Implants

May 18, 2023
Breast implant

Breast implant illness (BII) has been a hot topic in plastic surgery for several years. Patients experiencing a range of symptoms, from joint pain to chronic fatigue, attribute their conditions to their implants. However, until now, there has been scarce scientific evidence to support this claim. A recently published study funded by the Aesthetic Surgery Education and Research Foundation (ASERF) sheds new light on BII-related symptoms.

The principal investigators of the “Systemic Symptoms in Women — Biospecimen Analysis Study,” Wall Township, NJ plastic surgeon Caroline Glicksman, MD, who is also the president of the Aesthetic Society Education and Research Foundation (ASERF), and Saint Louis, MO plastic surgeon Patricia McGuire, MD spoke to us about the importance of their findings.

“Our study, funded by a ASERF grant, is the first prospective, blinded study to compare women with self-described breast implant illness to two control groups,” explains Dr. McGuire. “One of our goals was to prospectively follow symptom improvement after implant removal. Most studies are retrospective, meaning they aren’t done until after surgery, which can be subject to recall bias.”

Read more at New Beauty >>

Review Key Findings at ASERF >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Allergan Aesthetics’ Skinvive by Juvéderm Receives FDA Approval for the Improvement of Neck Appearance
    • Obagi Medical Announces FDA Approval of Obagi saypha ChIQ Injectable Hyaluronic Acid Gel
    • MedSafe Becomes Gold Vendor Affiliate with the American Med Spa Association
    • FDA Approves First New Sunscreen Ingredient in 20 Years
    • Allergan Aesthetics Releases ‘The Aesthetics Evolution: What Consumers Really Want’ Highlighting Consumer Motivations and Expectations in Aesthetics